Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed information about a Phase 3 study on pegcetacoplan for C3 glomerulopathy and related conditions, while adding new terminology related to C3 glomerulopathy and a new version revision number.SummaryDifference24%
- Check52 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 13, 2025.SummaryDifference0.2%
- Check59 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 13, 2025, and version 2.14.2.SummaryDifference0.2%
- Check74 days agoChange DetectedThe page has been updated with new dates and figures, including a completed status and specific dates in March 2025, while previous dates and estimates have been removed.SummaryDifference1%
Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.